Treatment of Non-small Cell Lung Cancer, Stage IV

This publication has 74 references indexed in Scilit:

• Adding Gemcitabine to Paclitaxel/Carboplatin Combination Increases Survival in Advanced Non–Small-Cell Lung Cancer: Results of a Phase II-III Study
  Journal of Clinical Oncology, 2006
• Phase III Trial of Gemcitabine Plus Carboplatin Versus Single-Agent Gemcitabine in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: The Swedish Lung Cancer Study Group
  Journal of Clinical Oncology, 2005
• Randomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18
  Journal of Clinical Oncology, 2005
• Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life
  Thorax, 2004
• Docetaxel Versus Docetaxel Plus Cisplatin As Front-Line Treatment of Patients With Advanced Non—Small-Cell Lung Cancer: A Randomized, Multicenter Phase III Trial
  Journal of Clinical Oncology, 2004
• Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma
  Cancer, 2003
• Quality of Life (QOL) Assessment of MIP (Mitomycin, Ifosfamide and Cisplatin) Chemotherapy in Advanced Non-small Cell Lung Cancers (NSCLC)
  Japanese Journal of Clinical Oncology, 1998
• Phase II study of patients with metastatic nonsmall cell carcinoma of the lung treated with paclitaxel by 3-hour infusion
  Cancer, 1997
• Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer
  Journal of Pain and Symptom Management, 1995
• Influence of extent of disease, histology, and demographic factors on lung cancer survival in the seer population‐based data
  Seminars in Surgical Oncology, 1994